Anthelmintics. A comparative review of their clinical pharmacology

Drugs

Volumn 53, Issue 5, 1997, Pages 769-788

  De Silva, Nilanthi ^a   Guyatt, Helen ^a   Bundy, Donald ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; DIETHYLCARBAMAZINE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; NICLOSAMIDE; OXAMNIQUINE; PRAZIQUANTEL; PREDNISOLONE; PYRANTEL EMBONATE; TIABENDAZOLE;

ALOPECIA; ANOREXIA; ARTHRALGIA; BONE MARROW DEPRESSION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ECHINOCOCCOSIS; EDEMA; EYE INFLAMMATION; FEVER; FILARIASIS; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL SYMPTOM; HEADACHE; HELMINTHIASIS; HUMAN; INFECTION CONTROL; LASSITUDE; LEUKOPENIA; MUSCLE WEAKNESS; NEMATODIASIS; NEUROCYSTICERCOSIS; NONHUMAN; ONCHOCERCIASIS; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PRURITUS; REVIEW; SCHISTOSOMIASIS; SIDE EFFECT; TREMATODIASIS; VERTIGO;

CESTODA; NEMATODA; SCHISTOSOMA; TREMATODA; VERMES;

EID: 0030899009     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199753050-00004     Document Type: Review

References (241)

1. Lacey E. Mode of action of benzimidazoles. Parasitol Today 1990; 6 (4): 107-12
2. Townsend LB, Wise DS. The synthesis and chemistry of certain anthelmintic benzimidazoles. Parasitol Today 1990; 6 (4): 107-12
3. Gottschall DW, Theodorides VJ, Wang R. The metabolism of benzimidazole anthelmintics. Parasitol Today 1990; 6 (4): 115-24
4. Albonico M, Smith PG, Hall A, et al. A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Trans R Soc Trop Med Hyg 1994; 88 (5): 585-9
5. Jongsuksuntigul P, Jeradit C, Pornpattanakul S, et al. A comparative study on the efficacy of albendazole and mebendazole in the treatment of ascariasis, hookworm infection and trichuriasis. Southeast Asian J Trop Med Public Health 1993; 24 (4): 724-9
6. Ismail MM, Premaratne UN, Suraweera MG. Comparative efficacy of single dose anthelmintics in relation to intensity of geohelminth infections. Ceylon Med J 1991; 36 (4): 162-7
7. Raccurt CP, Lambert MT, Bouloumie J, et al. Evaluation of the treatment of intestinal helminthiases with albendazole in Djohong (North Cameroon). Trop Med Parasitol 1990; 41 (1): 46-8
8. Sinniah B, Chew PI, Subramaniam K. A comparative trial of albendazole, mebendazole, pyrantel pamoate and oxantel pyrantel pamoate against soil-transmitted helminthiases in school children. Tropical Biomedicine 1990; 7 (2): 129-34
9. Nontasut P, SinghasivAnon V, Prarinyanuparp V. Effect of single-dose albendazole and single-dose mebendazole on Necator americanus. Southeast Asian J Trop Med Public Health 1989; 20 (2): 237-42
10. Pugh RNH, Teesdale CH, Burnham GM. Albendazole in children with hookworm infection. Ann Trop Med Parasitol 1986; 80 (5): 565-7
11. Prasad R, Mathur PP, Taneja VK, et al. Albendazole in the treatment of intestinal helminthiasis in children. Clin Ther 1985; 7 (2): 164-8
12. Bwibo NO, Pamba HO. Double-blind comparative study of albendazole and placebo in the treatment of intestinal helminths. In: Firth M, editor. Albendazole in helminthiasis. Royal Society of Medicine International Congress and Symposium series no. 61, Royal Society of Medicine, 1984: 47-53
13. Chen ER, Yen CM, Shih CC, et al. Albendazole in the treatment of common intestinal parasite infections among school children in Taiwan. J Formos Med Assoc 1984, 83 (6): 551-5
14. Coulaud JP, Rossignol JF, Albendazole: a new single dose anthetmintic; study in 1455 patients. Acta Trop 1984; 41 (1): 87-90
15. Chandiwana SK, Makaza D, Makura O. Study of albendazole in the treatment of intestinal helminthiasis in Zimbabwe. Cent Afr J Med 1983; 29 (11): 213-5
16. Chitchang S, Leelayoova S, Piamjinda T. Albendazole in treatment of hookworm infestation in Thailand. J Med Assoc Thai 1983; 66 (1): 45-8
17. Cruz O. Comparative evaluation of the effect of single doses of mebendazole and albendazole. Invest Med Int 1983; 10 (5): 404-6
18. Kan SP, Chua SH. The anthelmintic effect of albendazole on Trichuris trichiuria and Ascaris lumbricoides. Asian J Clin Sci 1983; 4 (3): 285-8
19. Morgan P, Yamamoto M, Teesdale C, et al. Albendazole: a new treatment for hookworm. Med Quarterly - J Med Assoc Malawi 1983; 16: 4-5
20. Albonico M, Renganathan E, Bosnian A, et al. Efficacy of a single dose of mebendazole on prevalence and intensity of soil transmitted nematodes in Zanzibar. Trop Geogr Med 1994; 46: 142-6
21. Ramirez Fernandez E, Miquet Romero L, Finlay C. Comparison of 3 single-dose mebendazole regimes for the treatment of trichuriasis. Rev Cubana Med Trop 1992; 44 (1): 21-4
22. Balasuriya S, Edirisinghe JS, Rajudeen NMM. Effectiveness of mass treatment with mebendazole in the control of soil transmitted helminths in Sri Lanka. Ceylon Med J 1990; 35 (1): 15-20
23. Abadi K. Single dose mebendazole therapy for soil-transmitted nematodes. Am J Trop Med Hyg 1985; 34 (1): 129-33
24. Farahmandian I, Sahba GH, Arfaa F, et al. Comparison of the effect of oxantel-pyrantel and mebendazole on soil-transmitted nematodes in Iran. Curr Ther Res 1979; 26 (1): 114-8
25. Chongsuphajaisiddhi T, Sabcharoen A, Attanath P, et al. Treatment of soil-transmitted nematode infections in children with mebendazole. Ann Trop Med Parasitol 1978; 72 (1): 59-63
26. Lionel NDW, Rajapakse L, Soysa P, et al. Mebendazole in the treatment of intestinal helminthiasis with special reference to whipworm infection. J Trop Med Hyg 1975; 78 (4): 75-7
27. Vandepitte J, Gatti F, Lontie M, et al. Mebendazole, new broad spectrum anthelmintic agent against trichocephalosis. Bull Soc Path Exotique 1973; 66: 165-78
28. Ahmad A, Zohra A, Yasmin N. 'Albendazole' in intestinal helminthiasis. JPMA J Pak Med Assoc 1986; 36 (5): 114-7
29. Almeida ISD. Therapeutic action of mebendazole on multiple enteroparasitic infections in children in N.S. de Fatima - Planaltina - DF - 1978. Rev Inst Med Trop Sao Paulo 1979; 21 (6): 339-43
30. Amato Neto V, Moreira AAB, Campos R, et al. Treatment of hookworm, ascariasis and trichuriasis with albendazole or mebendazole. Rev Inst Med Trop Sao Paulo 1983; 25 (6): 294-9
31. Bassily S, El Masry NA, Trabolsi B, et al. Treatment of ancylostomiasis and ascariasis with albendazole. Ann Trop Med Parasitol 1984; 78 (1): 81-2
32. Bastidas G. Albendazol a dosis unica en nematodiasis intestinales multiples. Invest Med Int 1982; 9: 308-12
33. Blechman MG. Clinical effectiveness of mebendazole in the treatment of trichuriasis. Curr Ther Res 1975; 18 (6): 800-3
34. Bunnag D, Harinasuta T, Vasuvat C, et al. Clinical trial of mebendazole on whipworm and hookworm. J Med Assoc Thai 1978; 61 (6): 319-22
35. Camillo-Coura L, Soli A, Willcox H. Ensaio com Albendazol no tratamento de helmintiases intestinais em criancas. A Folha Medica 1984; 88 Suppl. 1: 225-8
36. Charoenlarp P, Waikagul J, Muennoo C, et al. Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. Southeast Asian J Trop Med Public Health 1993; 24 (4): 712-6
37. Chien FL, Foon KLP, Hassan K. Efficacy of albendazole against the three common soil-transmitted helminthiases. Trop Biomed 1989; 6 (2): 133-6
38. Chobanov RE, Khanbutaev SN, Pogosyan EA. Clinical and epidemiological efficacy of new anthelmintics in foci of ascariasis and trichuriasis. Med Parazitol (Mosk) 1981; 50 (5): 55-9
39. Cortes R, Sanchez M, Espinoza G, et al. Albendazole in helminthiasis in children. Compend Invest Clin Latinoamer 1982; 2: 63-7
40. de Silva DG, Hettiarachchi SP, Fonseka PH. Albendazole in the treatment of geohelminth infections in children. Ceylon Med J 1989; 34 (4): 185-9
41. Gazder AJ, Roy J. Albendazole suspension in the treatment of intestinal helminthiasis in children. Curr Ther Res 1987; 41 (3): 324-7
42. Hanjeet K, Mathias RG. The efficacy of treatment with albendazole. Acta Trop 1991; 50 (2): 111-4
43. Jaroonvesama N, Charoenlarp K, Muangmanee L. Mebendazole, a new broad spectrum anthelmintic. J Med Assoc Thai 1978; 61 (12): 675-80
44. Jidy MD, Abascal HF, Marcelo JCM, et al. Levamisole, mebendazole, thiabendazole: their efficacy as anthelmintics in African patients recently arrived in Cuba in the period 1987-1988. Rev Cubana Med Trop 1990; 42 (2): 240-6
45. Kleiner M. Ensaio terapeutico com albendazol nas helmintiases intestinais - simples ou mistas. Arq Bras Med 1990; 64 (1): 58-60
46. Marcondes J, Meira D, Gushiken T, et al. Tratamento das helmintíases intestinais com Albendazole em indivíduos habitantes do município de Humaitá, Estado do Amazonas. A Folha Medica 1984; 88 Suppl. 1: 241-5
47. Misra PK, Pande NK, Jagota SC. Albendazole in the treatment of intestinal helminthiasis in children. Curr Med Res Opin 1985; 9 (8): 516-9
48. Nahmias J, Kennet R, Goldsmith R, et al. Evaluation of albendazole, pyrantel, bephenium, pyrantel-praziquantel and pyrantel-bephenium for single-dose mass treatment of necatoriasis. Ann Trop Med Parasitol 1989; 83 (6): 625-9
49. Nontasut P, SinghasivAnon V, Maipanich W, et al. Comparative study of different doses of mebendazole in hookworm infection. Southeast Asian J Trop Med Public Health 1987; 18 (2): 211-4
50. Ochoa G, Guerra A, Arango B, et al. Tratamiento de helmintiasis intestinales con albendazol en ninos de una comunidad colombiana. Invest Med Int 1989; 16: 125-30
51. Oyediran A, Oyejide CO. Double-blind comparative study of a new anthelmintic albendazole, in the treatment of intestinal helminths. In: Firth M, editor. Albendazole in helminthiasis. Royal Society of Medicine International Congress and Symposium series no. 61, Royal Society of Medicine, 1984: 69-76
52. Pene P, Mojon M, Garin JP, et al. Albendazole: a new broad spectrum anthelmintic: double-blind multicenter clinical trial. Am J Trop Med Hyg 1982; 31 (2): 263-6
53. Pereira JFV, Ghosh HK, Conklin S, et al. Mebendazole therapy of whipworm infestation: a clinical trial. Med J Aust 1979; 1 (4): 134-5
54. Ramalingam S, Sinniah B, Krishnan U. Albendazole, an effective single dose, broad spectrum anthelmintic drug. Am J Trop Med Hyg 1983; 32 (5): 984-9
55. Rim H-J, Joo K-Y, Lee J-S, et al. Anthelmintic effects of albendazole (Zentel) against helminthic infections. Korean J Parasitol 1984; 9 (1): 67-73
56. Sargent RG, Dotterer TD, Savory AM, et al. A clinical evaluation of the efficacy of mebendazole in the treatment of trichuriasis. South Med J 1975; 68 (1): 38-40
57. Schenone H, Galdames M, Inzunza E, et al. An oral suspension of mebendazole in the treatment of enterobiasis, ascariasis and trichuriasis in children: the therapeutic effectiveness of a single dose in enterobiasis. Bol Chil Parasitol 1976; 31: 3-4
58. Shiratsuchi MS, Levi GC, Amato Neto V, et al. Results of treatment of trichuriasis with mebendazole. Rev Inst Med Trop Sao Paulo 1975; 17 (3): 206-9
59. Singhal KC, Gupta MC, Saxena PN. A clinical trial with mebendazole in ascariasis and ankylostomiasis. J Assoc Physicians India 1975; 23 (12): 903-7
60. Sitthichareonchai P, Kulkumthorn M, Akarabovorn P. Clinical trial of a 400 mg dose of albendazole in hookworm infection in Chulalongkorn Hospital. Chulalongkorn Med J 1984; 28 (8): 909-13
61. Soh CT, Lee BH, Min DY, et al. Clinical trial of Vermox (R) (mebendazole). a new broadspectrum anthelmintic. Yonsei Reports Trop Med 1974; 5 (1): 148-52
62. Urquiaga J, Pavia N. Efficacy of albendazole against intestinal helminthiases. Invest Med Int 1982; 9 (3): 266-9
63. Varma TK, Shanghal TN, Saxena M, et al. Studies on comparative efficacy of drug mebendazole and flubendazole as broad spectrum anthelmintics. Indian J Parasitol 1991; 15 (2): 161-3
64. Viravan C, Migasena S, Bunnag D, et al. Clinical trial of albendazole in hookworm infection. Southeast Asian J Trop Med Public Health 1982; 13 (4): 654-7
65. Wesche D, Barnish G. A comparative study of the effectiveness of mebendazole (Janssen) and generically equivalent mebendazole (Nordia) in intestinal helminthiasis in Papua New Guinean children. P N G Med J 1994; 37 (1): 7-11
66. Zawde D. The treatment of intestinal helminthiasis with albendazole. Ethiop Med J 1987; 25 (2): 83-6
67. WHO. WHO Model Prescribing information - drugs used in parasitic diseases. 2nd edition. Geneva: WHO, 1995
68. Chunlertrith K, Mairiang P, Sukeepaisarnjaroen W. Intestinal capillariasis: a cause of chronic diarrhea and hypoalbuminemia. Southeast Asian J Trop Med Public Health 1992; 23 (3): 433-6
69. Dronda F, Chaves F, Sanz A, et al. Human intestinal capillariasis in an area of nonendemicity: case report and review. Clin Infect Dis 1993; 17 (5): 909-12
70. Mousa AM, Rudwan MA, Marafi AA, et al. Human cystic hydatid disease: treatment with interrupted courses of mebendazole. J Trop Med Hyg 1986; 89 (5): 257-64
71. Teggi A, Lastilla MG, De Rosa F. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 1993; 37 (8): 1679-84
72. Mravak S, Schopp W, Bienzle U. Treatment of strongyloidiasis with mebendazole. Acta Trop 1983; 40 (1): 93-4
73. Shikiya K, Zaha O, Niimura S, et al. Clinical study on ivermectin against 125 strongyloidiasis patients. Kansenshogaku Zasshi 1994; 68 (1): 13-20
74. Mittermayer T, Spaldonova R. The use of mebendazole in the treatment of trichinellosis in man. Folia Parasitol Praha 1981; 28 (3): 235-42
75. Levin ML. Treatment of trichinosis with mebendazole. Am J Trop Med Hyg 1983; 32 (5): 980-3
76. Magnaval JF, Charlet JP. Comparative efficacy of thiabendazole and mebendazole in the treatment of toxocariasis. Therapie 1987; 42 (6): 541-4
77. Magnaval JF, Charlet JP, de Larrard B. Double blind study of the efficacy of mebendazole in minor forms of human toxocariasis. Therapie 1992; 47 (2): 145-8
78. Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology 1995; 110 (5): 529-33
79. Wahlgren M. The successful treatment of Dipetalonema perstans filariasis with mebendazole. Ann Trop Med Parasitol 1982; 76 (5): 557-9
80. Van Hoegaerden M, Ivanoff B, Flocard F, et al. The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol 1987; 81 (3): 275-82
81. Chavarria AP, Villarejos VM, Zeledon R. Mebendazole in the treatment of taeniasis solium and taeniasis saginata. Am J Trop Med Hyg 1977; 26 (1): 118-20
82. Khalil HM, el Shimi S, Sarwat MA, et al. Recent study of Hymenolepis nana infection in Egyptian children. J Egypt Soc Parasitol 1991; 21 (1): 293-300
83. Reynolds JEF, editor. Martindale: the extra pharmacopoeia. 30th edition. London: Pharmaceutical Press, 1993
84. Seitz R, Schwerk W, Arnold R. Hepatocellular drug reaction caused by mebendazole therapy in cystic echinococcosis. Z Gastroenterol 1983; 21 (7): 324-9
85. Bekhti A, Pirotte J. Cimetidine increases serum mebendazole concentrations: implications for treatment of hepatic hydatid cysts. Br J Clin Pharmacol 1987; 24: 390-2
86. Miskovitz PF, Javitt NB. Leukopenia associated with mebendazole therapy of hydatid disease. Am J Trop Med Hyg 1980; 29 (6): 1356-8
87. Levin MH, Weinstein RA, Axelrod JL, et al. Severe, reversible neutropenia during high-dose mebendazole therapy for echinococcosis. Jama 1983; 249 (21): 2929-31
88. Kammerer WS, Schantz PM. Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. Am J Trop Med Hyg 1984; 33 (1): 132-7
89. Braithwaite PA, Thomas RJ, Thompson RC. Hydatid disease: the alveolar variety in Australia: a case report with comment on the toxicity of mebendazole. Aust N Z J Surg 1985; 55 (5): 519-23
90. Fernandez Banares F, Gonzalez Huix F, Xiol X, et al. Marrow aplasia during high dose mebendazole treatment. Am J Trop Med Hyg 1986; 35 (2): 350-1
91. Abdi Y, Gustaffson L, Ericsson O, et al. Handhook of drugs for tropical parasitic infections. 2nd ed. London: Taylor and Francis, 1995
92. Bogan JA, Marriner SE. Analysis of benzimidazoles in body fluids by high performance liquid chromatography. J Pharmacol Sci 1980; 69: 122-3
93. Hall A, Nahar Q. Albendazole and infections with Ascaris lumbricoides and Trichuris trichiara in children in Bangladesh. Trans R Soc Trop Med Hyg 1994; 88 (1): 110-2
94. Pitisuttithum P, Suparanond W, Chindanond D. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J Trop Med Public Health 1995; 26: 735-8
95. Datry A, Hilmarsdottir I, Mayorga Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88 (3): 344-5
96. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169 (5): 1076-9
97. Archibald LK, Beeching NJ, Gill GV, et al. Albendazole is effective treatment for chronic strongyloidiasis. Q J Med 1993; 86 (3): 191-5
98. Niimura S, Hirata T, Zaha O, et al. Clinical study of albendazole therapy for strongyloidiasis. Kansenshogaku Zasshi 1992; 66 (9): 1231-5
99. Cross JH, Basaca Sevilla V. Albendazole in the treatment of intestinal capillariasis. Southeast Asian J Trop Med Public Health 1987; 18 (4): 507-10
100. Chichino G, Bernuzzi AM, Bruno A, et al. Intestinal capillariasis (Capillaria philippinensis acquired in Indonesia: a case report. Am J Trop Med Hyg 1992; 47 (1): 10-2
101. Lee SH, Hong ST, Chai JY, et al. A case of intestinal capillariasis in the Republic of Korea. Am J Trop Med Hyg 1993; 48 (4): 542-6
102. Hong ST, Kim YT, Choe G, et al. Two cases of intestinal capillariasis in Korea. Korean J Parasitol 1994; 32 (1): 43-8
103. de Kaminsky RG. Albendazole treatment in human taeniasis. Trans R Soc Trop Med Hyg 1991; 85 (5): 648-50
104. Cruz M, Cruz I, Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg 1991; 85 (2): 244-7
105. Takayanagui OM, Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992; 49 (3): 290-4
106. Bolero D, Uribe CS, Sanchez JL, et al. Short course albendazole treatment for neurocysticercosis in Columbia. Trans R Soc Trop Med Hyg 1993; 87 (5): 576-7
107. Martinez HR, Rangel Guerra R, Arredondo Estrada JH, et al. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases. J Neurol Sci 1995; 130 (1): 25-34
108. Kraivichian P, Kulkumthorn M, Yingyourd P, et al. Albendazole for the treatment of human gnathostomiasis. Trans R Soc Trop Med Hyg 1992; 86 (4): 418-21
109. Meneghelli UG, Martinelli AL, Bellucci AD, et al. Polycystic hydatid disease (Echinococcus vogeli): treatment with albendazole. Ann Trop Med Parasitol 1992; 86 (2): 151-6
110. el Mufti M, Kamag A, Ibrahim H, et al. Albendazole therapy of hydatid disease: 2-year follow-up of 40 cases. Ann Trop Med Parasitol 1993; 87 (3): 241-6
111. Gil Grande LA, Rodriguez Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 1993; 342 (8882): 1269-72
112. Liu YH, Wang XG, Chen YT, et al. Computer tomography of liver in alveolar echinococcosis treated with albendazole. Trans R Soc Trop Med Hyg 1993; 87 (3): 319-21
113. Wen H, Zhang HW, Muhmut M, et al. Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis. Ann Trop Med Parasitol 1994; 88 (1): 49-52
114. Torres JR, Orihuela AR, Garcia D, et al. Treatment of cutaneous larva migrans with albendazole: preliminary report. Rev Inst Med Trop Sao Paulo 1989; 31 (1): 56-8
115. Caumes E, Carriere J, Datry A, et al. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 1993; 49 (5): 641-4
116. Kollaritsch H, Jeschko E, Wiedermann G. Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of an open pilot trial in travellers returning from the tropics. Trans R Soc Trop Med Hyg 1993; 87 (6): 689
117. Sturchler D, Schubarth P, Gualzata M, et al. Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Ann Trop Med Parasitol 1989; 83 (5): 473-8
118. Bhatia V, Sarin SK. Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol 1994; 89 (4): 624-7
119. Pungpark S, Bunnag D, Harinasuta T. Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections. Southeast Asian J Trop Med Public Health 1984; 15 (1): 44-50
120. Liu YH, Wang XG, Gao P, et al. Experimental and clinical trial of albendazole in the treatment of Clonorchiasis sinensis. Chin Med J Engl 1991; 104 (1): 27-31
121. Fourestie V, Bougnoux ME, Ancelle T, et al. Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res 1988; 75 (1): 36-41
122. Xu B, Chang J, Gao G, et al. Four outbreaks of human trichinellosis in Henan Province. Chin Med J (Engl) 1995; 108 (11): 872-4
123. Awadzi K, Hero M, Opoku O, et al. The chemotherapy of onchocerciasis. XV. Studies with albendazole. Trop Med Parasitol 1991; 42 (4): 356-60
124. Cline BL, Hernandez JL, Mather FJ, et al. Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela. Am J Trop Med Hyg 1992; 47 (4): 512-20
125. Klion AD, Massougbodji A, Horton J, et al. Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis 1993; 168 (1): 202-6
126. Morris DL, Smith PG. Albendazole in hydatid disease - hepatocellular toxicity. Trans R Soc Trop Med Hyg 1987; 81 (2): 343-4
127. Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 1989; 83 (1): 97-102
128. Steiger U, Cotting J, Reichen J. Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance. Clin Pharmacol Ther 1990; 47 (3): 347-53
129. Hewitt RI, Kushner S, Stewart H, et al. Experimental chemotherapy of filariasis III. Effect of 1-diethylcarbamyl-4-methylpiperazine hydrochloride against naturally acquired filarial infection in cotton rats and dogs. J Lab Clin Med 1947; 32: 1314-29
130. Gelband H. Diethylcarbamazine salt in the control of lymphatic filariasis. Am J Trop Med Hyg 1994; 50 (6): 655-62
131. Adjepon-Yamoah KK, Edwards G, Breckenridge AM, et al. The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man. Br J Clin Pharmacol 1982; 13: 829-34
132. Langham ME, Kramer TR. The 'in vitro' effect of diethylcarbamazine on the motility and survival of Onchocerca volvulus microfilariae. Tropenmed Parasitol 1980; 31 (1): 59-66
133. Cesbron JY, Capron A, Vargaftig BB, et al. Platelets mediate the action of diethylcarbamazine on microfilariae. Nature 1987; 325 (6104): 533-6
134. Maizels RM, Denham DA. Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 1992; 105: S49-60
135. Maizels RM, Bundy DAP, Selkirk ME, et al. Immunological modulation and evasion by helminth parasites in human populations. Nature 1993; 365: 797-805
136. Fujimaki Y, Ehara M, Kimura E, et al. Diethylcarbamazine, antifilarial drug, inhibits microtubule polymerization and disrupts preformed microtubules. Biochem Pharmacol 1990; 39 (5): 851-6
137. Figueredo-Silva J, Jungmann P, Noroes J, et al. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis. Trans R Soc Trop Med Hyg 1996; 90: 192-4
138. Gilles HM. Soil-transmitted helminths (geohelminths). In: Cook GC, editor. Manson's tropical diseases. 20 edition. London: WB Saunders Company, 1996: 1369-412
139. Dreyer G, Pires ML, de Andrade LD, et al. Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil. Trans R Soc Trop Med Hyg 1994; 88 (2): 232-6
140. Albiez EJ, Newland HS, White AT, et al. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects. Trop Med Parasitol 1988; 39 (1): 19-24
141. Carme B, Boulesteix J, Boutes H, et al. Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am J Trop Med Hyg 1991; 44: 684-90
142. Goa KL, McTavish D, Clissold SP. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 1991; 42: 640-58
143. Ottesen EA, Campbell WC. Ivermectin in human medicine. J Antimicrob Chemother 1994; 34 (2): 195-203
144. Whitworth JAG. Filariases. Curr Opin Infect Dis 1994; 7: 696-700
145. Boussinesq M, Chippaux JP, Ernould JC, et al. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon. Am J Trop Med Hyg 1995; 53 (1): 63-7
146. Kumaraswami V, Ottesen EA, Vijayasekaran V, et al. Ivermectin for the treatment of Wuchereria bancrofti filariasis: efficacy and adverse reactions [published erratum appears in JAMA 1988 Aug 5; 260 (5): 640]. JAMA 1988; 259 (21): 3150-3
147. Coutinho AD, Dreyer G, Modeiros Z, et al. Ivermectin treatment of bancroftian filariasis in Recife, Brazil. Am J Trop Med Hyg 1994; 50: 339-48
148. Moulia-Pelat J-P, Glaziou P, Nguyen LN, et al. Ivermectin 400 mcg/kg: long-term suppression of microfilariae in bancroftian filariasis. Tran R Soc Trop Med Hyg 1994; 88: 107-9
149. Shenoy RK, Kumaraswami V, Rajan K, et al. A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis. Ann Trop Med Parasitol 1993; 87 (5): 459-67
150. Richard Lenoble D, Kombila M, Rupp EA, et al. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. Am J Trop Med Hyg 1988; 39 (5): 480-3
151. Martin Prevel Y, Cosnefroy JY, Tshipamba P, et al. Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg 1993; 48 (2): 186-92
152. Ducorps M, Gardon Wendel N, Ranque S, et al. Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin. Bull Soc Pathol Exot 1995; 88 (3): 105-2
153. Nutman TB, Nash TE, Ottesen EA. Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection. J Infect Dis 1987; 156 (4): 662-5
154. Dreyer G, Noroes J, Amaral F, et al. Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. Trans R Soc Trop Med Hyg 1995; 89 (4): 441-3
155. Torres JR, Isturiz R, Murillo J, et al. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis 1993; 17 (5): 900-2
156. Whitworth JA, Morgan D, Maude GH, et al. A field study of the effect of ivermectin on intestinal helminths in man. Trans R Soc Trop Med Hyg 1991; 85 (2): 232-4
157. Xia ZH, Su YL, Yao SY, et al. Clinical observation on efficacy of ivermectin in the treatment of intestinal nematode infections. Chung Kuo Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih 1992; 10 (4): 279-82
158. Behnke JM, Pritchard DI, Wakelin D, et al. Effect of ivermectin on infection with gastro-intestinal nematodes in Sierra Leone. J Helminthol 1994; 68 (3): 187-95
159. Pacque M, Munoz B, Greene BM, et al. Safety of and compliance with community-based ivermectin therapy. Lancet 1990; 335 (8702): 1377-80
160. De Sole G, Awadzi K, Remme J, et al. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II: adverse reactions. Trop Med Parasitol 1989; 40 (3): 375-82
161. Pacque M, Munoz B, Poetschke G, et al. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Lancet 1990; 336 (8729): 1486-9
162. King CH, Lombardi G, Lombardi C, et al. Chemotherapy-based control of schistosomiasis haematobia. I: metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 1988; 39 (3): 295-305
163. Taddese K, Zein ZA. Comparison between the efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infections on a sugar estate in Ethiopia. Ann Trop Med Parasitol 1988; 82 (2): 175-80
164. Stephenson LS, Kinoti SN, Latham MC, et al. Single dose metrifonate or praziquantel treatment in Kenyan children. I: effects on Schistosoma haematobium, hookworm, hemoglobin levels, splenomegaly, and hepatomegaly. Am J Trop Med Hyg 1989; 41 (4): 436-4
165. King CH, Muchiri E, Ouma JH, et al. Chemotherapy-based control of Schistosoma haematobium. IV: impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 1991; 45 (4): 498-508
166. Wu MH, Wei CC, Xu ZY, et al. Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica. Am J Trop Med Hyg 1991; 45 (3): 345-9
167. Metwally A, Bennett J, Botros S, et al. Impact of drug dosage and brand on bioavailability and efficacy of praziquantel. Pharmacol Res 1995; 31 (1): 53-9
168. Yangco BG, De Lerma C, Lyman GH, et al. Clinical study evaluating efficacy of praziquantel in clonorchiasis. Antimicrob Agents Chemother 1987; 31 (2): 135-8
169. Kieu TL, Bronshtein AM, Sabgaida TP. Clonorchiasis in the People's Republic of Vietnam. 2: the clinico-parasitological examination of a locus and a trial of praziquantel treatment. Med Parazitol (Mosk) 1992; 4: 7-11
170. Wang XG, Lin YH, Yan XH. A comparative trial of levopraziquantel and praziquantel in the treatment of human Clonorchis sinensis infection. Chung Hua Nei Ko Tsa Chih 1992; 31 (4): 233-5, 256
171. Li S, He G, Lu Z, et al. Efficacy of praziquantel combined with albendazole in the treatment of clonorchiasis. Chung Kuo Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih 1995; 13 (1): 61-3
172. Udonsi JK. Clinical field trials of praziquantel in pulmonary paragonimiasis due to Paragonimus uterobilateralis in endemic populations of the Igwun Basin, Nigeria. Trop Med Parasitol 1989; 40 (1): 65-8
173. Farag HF, Ragab M, Salem A, et al. A short note on praziquantel in human fascioliasis. J Trop Med Hyg 1986; 89 (2): 79-80
174. Fan PC, Chung WC, Chan CH, et al. Studies on taeniasis in Taiwan. V. Field trial on evaluation of therapeutic efficacy of mebendazole and praziquantel against taeniasis. Southeast Asian J Trop Med Public Health 1986; 17 (1): 82-90
175. Carpio A, Santillan F, Leon P, et al. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995; 155 (18): 1982-8
176. Davis A, Biles JE, Ulrich AM. Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium. Bull World Health Organ 1979; 57: 773-9
177. Dollery C, ed. Therapeutic drugs. Edinburgh: Churchill Livingstone, 1991
178. Savioli L, Bundy D, Tomkins A. Intestinal parasitic infections: a soluble public health problem. Trans R Soc Trop Med Hyg 1992; 86: 353-4
179. Thein H, Thane T, Than S, et al. A controlled chemotherapeutic intervention trial on the relationship between Ascaris lumbricoides infection and malnutrition in children. Trans R Soc Trop Med Hyg 1991; 85 (4): 523-8
180. Stephenson L, Latham M, Adams E, et al. Weight gain of Kenyan school children infected with hookworm, Trichuris trichiura and Ascaris lumbricoides is improved following once- or twice-yearly treatment with albendazole. J Nutr 1993; 123: 656-65
181. Stephenson L, Latham M, Adams E, et al. Physical fitness, growth and appetite of Kenyan schoolboys with hookworm. Trichuris trichiura and Ascaris lumbricoides infections are improved four months after a single dose of albendazole. J Nutr 1993; 123: 1036-46
182. Nokes C, Bundy D. Does helminth infection affect mental processing and educational achievement? Parasitol Today 1994; 10 (1): 14-8
183. Guyatt H, Chan M, Medley G, et al. Control of Ascaris infection by chemotherapy: which is the most cost-effective option? Trans R Soc Trop Med Hyg 1995; 89: 16-20
184. Albonico M, Smith PG, Ercole E, et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg 1995; 89 (5): 538-41
185. Bundy DA, Wong MS, Lewis LL, et al. Control of geohelminths by delivery of targeted chemotherapy through schools. Trans R Soc Trop Med Hyg 1990; 84 (1): 115-20
186. Cartel JL, Spiegel A, Nguyen Ngnoc L, et al. Compared efficacy of repealed annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation. Trop Med Parasitol 1992; 43(2): 91-4
187. Glaziou P, Moulia Pelat JP, et al. Double-blind controlled trial of a single dose of the combination ivermectin 400 micrograms/kg plus diethylcarbamazine 6 mg/kg for the treatment of bancroftian filariasis: results at six months. Trans R Soc Trop Med Hyg 1994; 88(6): 707-8
188. Moulia Pelat JP, Nguyen LN, Hascoet H, et al. Advantages of an annual single dose of ivermectin 400 micrograms/kg plus diethylcarbamazine for community treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 1995; 89(6): 682-5
189. Addiss DG, Eberhard ML, Lammie PJ, et al. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia. Am J Trop Med Hyg 1993; 48(2): 178-85
190. Andrade LD, Medeiros Z, Pires ML, et al. Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis. Trans R Soc Trop Med Hyg 1995; 89 (3): 319-21
191. Dreyer G, Coutinho A, Miranda D, et al. Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine. Trans R Soc Trop Med Hyg 1995; 89 (1): 98-102
192. Meyrowitsch DW, Simonsen PE, Makunde WH. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments. Trans R Soc Trop Med Hyg 1996; 90: 69-73
193. Mak JW, Navaratnam V, Grewel JS, et al. Treatment of subperiodic Brugia malayi infection with a single dose of ivermectin. Am J Trop Med Hyg 1993; 48
194. Hakim SL, Vythilingam I, Marzukhi MI, et al. Single-dose diethylcarbamazine in the control of periodic brugian filariasis in Peninsular Malaysia. Trans R Soc Trop Med Hyg 1995; 89 (6): 686-9
195. Reddy GS, Sambasivam V, Venkateswaralu N. Control of bancroftian filariasis by salt medicated with diethylcarbamazine citrate. J Indian Med Assoc 1986; 84 (1): 1-3
196. Narasimham MV, Sharma SP, Sundaram RM, et al. Control of bancroftian filariasis by diethylcarbamazine medicated common salt in Karaikal, Pondicherry, India. J Commun Dis 1989; 21 (3): 157-70
197. Liu J, Chen Z, Huang X, et al. Mass treatment of filariasis using DEC-medicated salt. J Trop Med Hyg 1992; 95 (2): 132-5
198. Casley Smith JR, Jamal S, Casley Smith J. Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-alpha-pyrone (coumarin), and the effects of diethylcarbamazine (DEC). Ann Trop Med Parasitol 1993; 87 (3): 247-58
199. Cupp EW, Ochoa JO, Collins RC, et al. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg 1992; 47 (2): 170-80
200. Alley ES, Plaisier AP, Boatin BA, et al. The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg 1994; 88 (5): 581-4
201. Baraka OZ, Khier MM, Ahmed KM, et al. Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions. Trans R Soc Trop Med Hyg 1995; 89 (3): 316-8
202. Baraka OZ, Mahmoud BM, Ali MM, et al. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan. Trans R Soc Trop Med Hyg 1995; 89 (3): 312-5
203. Burnham G. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. Am J Trop Med Hyg 1995; 52 (3): 270-6
204. Rodriguez Perez MA, Rodriguez MH, Margeli Perez HM, et al. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico. Am J Trop Med Hyg 1995; 52 (5): 429-34
205. Warren KS, Bundy DAP, Anderson RM, et al. Helminth infections. In Disease control priorities in devloping countries. Jamison DT, Mosley WH, Measham AR et al., editors. Oxford: Oxford University Press 1993: 131-60
206. WHO. The control of schistosomiasis. WHO Technical Report Series 830, Geneva: WHO, 1993
207. Homeida MA, Daffalla AA, Nash TE. Effect of antischistosomal chemotherapy on prevalence of Symmer's periportal fibrosis in Sudanese villages. Lancet 1988; 11: 437-40
208. Homeida MA, Al Tom I, Nash T, et al. Assocaition of the therapeutic activity of praziquantel with the reversal of Symmer's fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg 1991; 45: 360-5
209. Butterworth AE, Sturrock RF, Ouma JH, et al. Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity. Parasitology 1991; 103: 339-55
210. Lengeler C, de Savigny D, Mshinda H, et al. Community-based questionnaires and health statistics as tools for the cost-efficainet identification of communities at risk of urinary schistosomiasis. Int J Epidemiol 1991; 20: 796-807
211. Guyatt HL, Evans D, Lengeler C, et al. Controlling schistosomiasis: the cost-effectiveness of alterantive delivery strategies. Health Policy Plan 1994; 9: 385-95
212. Vivatanasesth P, Sommani S, Schelp FP, et al. Mass treatment of opisthorchiasis in Northeast Thailand. Southeast Asian J Trop Med Public Health 1982; 13 (4): 609-13
213. Zavoikin VD, Zelia OP, Bronshtein AM, et al. The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 1: the tolerance and efficacy of different doses of biltricide during outpatient use in foci. Med Parazitol (Mosk) 1994 Jul-Sep; (3): 24-7
214. Bunnag D, Radomyos P, Harinasuta T. Field trial on the treatment of fasciolopsiasis with praziquantel. Southeast Asian J Trop Med Public Health 1983; 12 (2): 216-9
215. Benjapong W, Naeypatimanond S, Benjapong K, et al. Studies on paragonimiasis: treatment with mebendazole, emetine with mebendazole and praziquantel. Southeast Asian J Trop Med Public Health 1984; 15 (3): 354-9
216. Hammouda NA, el Mansoury ST, el Azzouni MZ, et al. Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt: a preliminary study. J Egypt Soc Parasitol 1995; 15 (1): 137-43
217. Lee SH. Large scale treatment of Clonorchis sinensis infections with praziquantel under field conditions. Arzneimittel Forschung 1984; 34 (9B): 1227-30
218. Cruz I, Cruz ME, Carrasco F, et al. Neurocysticercosis: optimal dose treatment with albendazole. J Neurol Sci 1995; 133 (1-2): 152-4
219. Escobedo F, Penagos P, Rodriguez J, et al. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987; 147: 738-41
220. Bryceson ADM, Cowie AGA, Macleod C, et al. Experience with mebendazole in the treatment of inoperable hydatid disease in England. Trans R Soc Trop Med Hyg 1982; 76: 510-8
221. Ammann R, Tschudi K, von Ziegler M, et al. The long-term course of 60 patients with alveolar echinococcosis in continuous therapy with mebendazole (1976-85). Klin Wochenschr 1988; 66: 1060-73
222. Bartoloni C, Tricerri A, Guidi L, et al. The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients. Ann Trop Med Parasitol 1992; 86 (3): 249-56
223. Wen H, Zou PF, Yang WG, et al. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China. Trans R Soc Trop Med Hyg 1994; 88 (3): 340
224. Luder PJ, Siffert B, Witassek F, et al. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. Eur J Clin Pharmacol 1986; 31: 443-8
225. WHO. Health of school children: treatment of intestinal helminths and schistosomiasis. 1995 WHO/SCHISTO/95.112. WHO/CDS/95.1
226. Shepard TH. Catalog of teratogenic agents. 4th ed. Baltimore: Johns Hopkins Hospital, 1983
227. Auer H, Kollaritsch H, Juptner J, et al. Albendazole and pregnancy. Appl Parasitol 1994; 35 (2): 146-7
228. Frohberg H. Results of toxicological studies on praziquantel. Arzneimittelforschung 1984; 34: 1137-44
229. Dorny P, Claerebout E, Vercruysse J, et al. Anthelmintic resistance in goats in peninsular Malaysia. Vet Parasitol 1994; 55 (4): 327-42
230. Grimshaw WT, Hunt KR, Hong C, et al. Detection of anthelmintic resistant nematodes in sheep in southern England by a faecal egg count reduction test. Vet Rec 1994; 135 (16): 372-4
231. Overend DJ, Phillips ML, Poulton AL, et al. Anthelmintic resistance in Australian sheep nematode populations. Aust Vet J 1994; 71 (4): 117-21
232. Pandey VS, Sivaraj S. Anthelmintic resistance in Haemonchus contortus from sheep in Malaysia. Vet Parasitol 1994; 53 (1-2): 67-74
233. Rahman WA. Resistance to benzimidazole anthelmintics by Haemonchus contortus in goats in peninsular Malaysia. Vet Parasitol 1994; 55 (1-2): 155-7
234. Sivaraj S, Dorny P, Vercruysse J, et al. Multiple and multigeneric anthelmintic resistance on a sheep farm in Malaysia. Vet Parasitol 1994; 55 (1-2): 159-65
235. Vermunt JJ, West DM, Pomroy WE. Multiple resistance to ivermectin and oxfendazole in Cooperia species of cattle in New Zealand. Vet Rec 1995; 137 (2): 43-5
236. Echevarria F, Borba MF, Pinheiro AC, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Brazil. Vet Parasitol 1996; 62 (3-4): 199-206
237. Eddi C, Caracostantogolo J, Pena M, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Argentina. Vet Parasitol 1996; 62 (3-4): 189-97
238. Maciel S, Gimenez AM, Gaona C, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Paraguay. Vet Parasitol 1996; 62 (3-4): 207-12
239. Nari A, Salles J, Gil A, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Uruguay. Vet Parasitol 1996; 62 (3-4): 213-2
240. Stelma FF, Talla I, Sow S, et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 1995; 53 (2): 167-70
241. Fallon PG, Sturrock RF, Niang AC, et al. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 1995; 53 (1): 61-2